Doug Schenkel
Stock Analyst at Wolfe Research
(4.57)
# 291
Out of 4,479 analysts
45
Total ratings
54.76%
Success rate
35.89%
Average return
Main Sectors:
30 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Downgrades: Peer Perform | n/a | $125.78 | - | 3 | Jun 27, 2024 | |
| QGEN Qiagen | Upgrades: Outperform | $50 | $40.70 | +22.85% | 2 | Jun 27, 2024 | |
| TXG 10x Genomics | Downgrades: Peer Perform | n/a | $18.87 | - | 3 | Jun 27, 2024 | |
| ILMN Illumina | Initiates: Outperform | n/a | $105.51 | - | 2 | Dec 13, 2023 | |
| EXAS Exact Sciences | Initiates: Outperform | n/a | $43.17 | - | 4 | Dec 13, 2023 | |
| TMO Thermo Fisher | Initiates: Outperform | n/a | $533.93 | - | 3 | Dec 13, 2023 | |
| MYGN Myriad Genetics | Initiates: Outperform | n/a | $24.76 | - | 1 | Dec 13, 2023 | |
| BRKR Bruker | Initiates: Outperform | n/a | $61.64 | - | 1 | Dec 13, 2023 | |
| RVTY Revvity | Initiates: Peer Perform | n/a | $102.01 | - | 1 | Dec 13, 2023 | |
| PACB Pacific Biosciences of California | Initiates: Peer Perform | n/a | $1.28 | - | 1 | Dec 13, 2023 | |
| AVTR Avantor | Initiates: Peer Perform | n/a | $20.58 | - | 1 | Dec 13, 2023 | |
| GH Guardant Health | Initiates: Peer Perform | n/a | $28.87 | - | 2 | Dec 13, 2023 | |
| NTRA Natera | Initiates: Outperform | n/a | $110.70 | - | 2 | Dec 13, 2023 | |
| WAT Waters | Initiates: Peer Perform | n/a | $284.49 | - | 1 | Dec 13, 2023 | |
| DHR Danaher | Initiates: Peer Perform | n/a | $240.41 | - | 1 | Dec 13, 2023 | |
| SOPH SOPHiA GENETICS | Initiates: Outperform | n/a | $4.59 | - | 1 | Aug 17, 2021 | |
| ABSI Absci | Initiates: Market Perform | n/a | $2.97 | - | 1 | Aug 16, 2021 | |
| SERA Sera Prognostics | Initiates: Outperform | n/a | $5.59 | - | 1 | Aug 9, 2021 | |
| OMIC Singular Genomics Systems | Initiates: Outperform | n/a | $8.51 | - | 1 | Jun 21, 2021 | |
| MASS 908 Devices | Initiates: Outperform | n/a | $4.73 | - | 1 | Jan 12, 2021 | |
| SEER Seer, Inc. | Initiates: Outperform | n/a | $1.64 | - | 1 | Dec 29, 2020 | |
| BNR Burning Rock Biotech | Initiates: Outperform | n/a | $6.20 | - | 1 | Jul 7, 2020 | |
| HOLX Hologic | Upgrades: Outperform | n/a | $73.53 | - | 3 | Jun 30, 2020 | |
| TWST Twist Bioscience | Initiates: Outperform | n/a | $47.32 | - | 1 | Nov 26, 2018 | |
| CDXS Codexis | Initiates: Outperform | n/a | $2.89 | - | 1 | Jun 19, 2018 | |
| TNDM Tandem Diabetes Care | Upgrades: Outperform | n/a | $39.15 | - | 1 | Mar 28, 2018 | |
| PODD Insulet | Maintains: Outperform | n/a | $197.19 | - | 1 | Feb 22, 2018 | |
| QTRX Quanterix | Initiates: Outperform | n/a | $12.72 | - | 1 | Jan 2, 2018 | |
| CHKP Check Point Software | Downgrades: Market Perform | n/a | $167.73 | - | 1 | Nov 1, 2017 | |
| DXCM DexCom | Maintains: Outperform | n/a | $112.49 | - | 1 | Sep 28, 2017 |
Agilent Technologies
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $125.78
Upside: -
Qiagen
Jun 27, 2024
Upgrades: Outperform
Price Target: $50
Current: $40.70
Upside: +22.85%
10x Genomics
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $18.87
Upside: -
Illumina
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $105.51
Upside: -
Exact Sciences
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $43.17
Upside: -
Thermo Fisher
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $533.93
Upside: -
Myriad Genetics
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $24.76
Upside: -
Bruker
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $61.64
Upside: -
Revvity
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $102.01
Upside: -
Pacific Biosciences of California
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.28
Upside: -
Avantor
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $20.58
Upside: -
Guardant Health
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $28.87
Upside: -
Natera
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $110.70
Upside: -
Waters
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $284.49
Upside: -
Danaher
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $240.41
Upside: -
SOPHiA GENETICS
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.59
Upside: -
Absci
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $2.97
Upside: -
Sera Prognostics
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.59
Upside: -
Singular Genomics Systems
Jun 21, 2021
Initiates: Outperform
Price Target: n/a
Current: $8.51
Upside: -
908 Devices
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.73
Upside: -
Seer, Inc.
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.64
Upside: -
Burning Rock Biotech
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $6.20
Upside: -
Hologic
Jun 30, 2020
Upgrades: Outperform
Price Target: n/a
Current: $73.53
Upside: -
Twist Bioscience
Nov 26, 2018
Initiates: Outperform
Price Target: n/a
Current: $47.32
Upside: -
Codexis
Jun 19, 2018
Initiates: Outperform
Price Target: n/a
Current: $2.89
Upside: -
Tandem Diabetes Care
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $39.15
Upside: -
Insulet
Feb 22, 2018
Maintains: Outperform
Price Target: n/a
Current: $197.19
Upside: -
Quanterix
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $12.72
Upside: -
Check Point Software
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $167.73
Upside: -
DexCom
Sep 28, 2017
Maintains: Outperform
Price Target: n/a
Current: $112.49
Upside: -